A randomized phase III trial comparing neoadjuvant chemotherapy with weekly nanoparticle-based paclitaxel with solventbased paclitaxel followed by anthracyline/ cyclophosphamide for patients with early breast cancer presented by Dr. Sunil Verma
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content